Fingerprint
Dive into the research topics of 'FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy
Aanchal Rathi, Saba Noor, Md Nayab Sulaimani, Shahbaz Ahmed, Aaliya Taiyab, Mohamed F. AlAjmi, Faez Iqbal Khan, Md Imtaiyaz Hassan*, Mohammad Mahfuzul Haque*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review